Milbemycin Oxime / Lufenuron Formulation

Hazard statements (CLP)

H317, H360D, H372

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

OSHA Hazards GHS classification in accordance with the OSHA Hazard Communication Standard (29 CFR 1910.1200) Skin sensitization Category 1 Reproductive toxicity Category 1B Specific target organ toxicity Category 1 (Central nervous system) - repeated exposure Specific target organ toxicity Category 1 (Central nervous system, Lungs, Liver, Stomach) - repeated exposure (Oral)

Signal word

Danger

Hazard statements

H317 May cause an allergic skin reaction. H360D May damage the unborn child. H372 Causes damage to organs (Central nervous system) through prolonged or repeated exposure. H372 Causes damage to organs (Central nervous system, Lungs, Liver, Stomach) through prolonged or repeated exposure if swallowed.

Prevention

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust, fume, gas, mist, vapors or spray. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves, protective clothing, eye protection and face protection.

Response

P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P308 + P313 IF exposed or concerned: Get medical attention. P333 + P313 If skin irritation or rash occurs: Get medical atten- tion. P363 Wash contaminated clothing before reuse.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents and container to an approved waste disposal plant.

2.3 Other hazards

None known.